Background The BNT162b2 mRNA (Pfizer–BioNTech) and ChAdOx1 nCoV-19 (Oxford–AstraZeneca)
COVID-19 vaccines have shown high efficacy against disease in phase 3 clinical …

Background There are few primary care studies of the COVID-19 pandemic. We aimed to
identify demographic and clinical risk factors for testing positive for severe acute respiratory …

Approximately 1.5 billion people worldwide are overweight or affected by obesity, and are at
risk of developing type 2 diabetes, cardiovascular disease and related metabolic and …

Objective. The purpose of this study was to examine whether Internet-based surveys of
health professionals can provide a valid alternative to traditional survey methods. Methods. (i) …

Reports of ChAdOx1 vaccine–associated thrombocytopenia and vascular adverse events
have led to some countries restricting its use. Using a national prospective cohort, we …

Background Indian Asians, who make up a quarter of the world's population, are at high risk
of developing type 2 diabetes. We investigated whether DNA methylation is associated with …

Background A previous efficacy trial found benefit from inhaled budesonide for COVID-19 in
patients not admitted to hospital, but effectiveness in high-risk individuals is unknown. We …

Background Current UK vaccination policy is to offer future COVID-19 booster doses to
individuals at high risk of serious illness from COVID-19, but it is still uncertain which groups of …

Introduction. Routinely collected primary care data has underpinned research that has helped
define primary care as a specialty. In the early years of the discipline, data were collected …

Eurosurveillance | Low levels of respiratory syncytial virus activity in Europe during the 2020/21
season: what can we expect in the coming summer and autumn/winter? 1887 Other sites…